
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
Keywords: ACS; acute coronary syndrome; apoB; apolipoprotein B; apoE; apolipoprotein E; AWARD program; efficacy and safety of dulaglutide in the treatment of type 2 diabetes; BP; blood pressure; cIMT; carotid intima media thickness; CV; cardiovascular; CVD; CV dise